Literature DB >> 11305600

Evaluation of insulin permeability and effects of absorption enhancers on its permeability by an in vitro pulmonary epithelial system using Xenopus pulmonary membrane.

A Yamamoto1, H Tanaka, S Okumura, K Shinsako, M Ito, M Yamashita, N Okada, T Fujita, S Muranishi.   

Abstract

The permeability of insulin across Xenopus pulmonary membrane and the effects of various absorption enhancers on insulin permeability were examined using an in vitro Ussing chamber technique. Absorption enhancers used in this study were sodium caprate (NaCap), sodium glycocholate (NaGC), sodium salicylate (NaSal) and ethylenediaminetetraacetic acid disodium salt (EDTA). The permeability of insulin across Xenopus pulmonary membrane significantly increased in the presence of NaCap and NaGC, while EDTA and NaSal did not enhance the permeability. In addition, the enhancing effect of NaGC increased as the concentrations of these enhancers increased. Transmembrane resistance (Rm) of Xenopus lung was markedly decreased in the presence of these enhancers, and NaCap showed a greater effect on Rm than NaGC. Furthermore, the amount of alkaline phosphatase (ALP) and lactate dehydrogenase (LDH) released from the apical side of the Xenopus pulmonary membrane increased in the presence of these enhancers. These results indicate that NaCap and NaGC improve the pulmonary absorption of insulin, but they are toxic to the pulmonary membrane. These findings suggest that this method is useful for estimating the permeability characteristics of peptides across the pulmonary membrane and for evaluating the effects of various additives on their permeability and their membrane toxicity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11305600     DOI: 10.1248/bpb.24.385

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  5 in total

1.  Challenges and Future Prospects for the Delivery of Biologics: Oral Mucosal, Pulmonary, and Transdermal Routes.

Authors:  Javier O Morales; Kristin R Fathe; Ashlee Brunaugh; Silvia Ferrati; Song Li; Miguel Montenegro-Nicolini; Zeynab Mousavikhamene; Jason T McConville; Mark R Prausnitz; Hugh D C Smyth
Journal:  AAPS J       Date:  2017-02-13       Impact factor: 4.009

Review 2.  Clinical pharmacokinetics and pharmacodynamics of inhaled insulin.

Authors:  John S Patton; Julie G Bukar; Michael A Eldon
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

3.  Insulin-induced electrophysiology changes in human pleura are mediated via its receptor.

Authors:  V K Kouritas; M Ioannou; C N Foroulis; N Desimonas; K Evaggelopoulos; K I Gourgoulianis; P A Molyvdas; C Hatzoglou
Journal:  Exp Diabetes Res       Date:  2010-08-12

Review 4.  Pulmonary route of administration is instrumental in developing therapeutic interventions against respiratory diseases.

Authors:  Xue Jin; Ling Song; Chao-Chao Ma; Yan-Chun Zhang; Shui Yu
Journal:  Saudi Pharm J       Date:  2020-11-04       Impact factor: 4.330

Review 5.  Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases.

Authors:  Malgorzata Smola; Thierry Vandamme; Adam Sokolowski
Journal:  Int J Nanomedicine       Date:  2008
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.